Veracyte, Inc. (VCYT) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-25 22:17:50 ET
Veracyte, Inc. (VCYT) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST
Company Participants
Shayla Gorman - Director of Investor Relations
Marc Stapley - CEO & Director
Rebecca Chambers - Executive VP & CFO
John Leite - Global Chief Commercial Officer
Phillip Febbo - Chief Scientific & Medical Officer
...
Read the full article on Seeking Alpha
For further details see:
Veracyte, Inc. (VCYT) Q4 2025 Earnings Call Transcript
Veracyte Inc.
NASDAQ: VCYT
VCYT Trading
-4.23% G/L:
$33.72 Last:
159,325 Volume:
$33.34 Open:
VCYT Latest News
February 25, 2026 04:05:00 pm
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
VCYT Stock Data
$2,908,219,075
77,942,485
0.94%
127
N/A
Medical Diagnostics & Screening
Healthcare
US
South San Francisco
